Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
Meeting ReportOncology: Clinical Diagnosis

The SUVmax (maximum standardized uptake value for F-18 fluorodeoxyglucose) and serum squamous cell carcinoma antigen (SCC-ag) function as prognostic biomarkers in patients with primary cervical cancer

LingLing Pan, Jingyi Cheng, Min Zhou, ZhiFeng Yao and Yingjian Zhang
Journal of Nuclear Medicine May 2012, 53 (supplement 1) 67;
LingLing Pan
1Nuclear Medicine, Shanghai Cancer Center, Fudan University, Department of Oncology, Shanghai Medical College, Shanghai, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jingyi Cheng
1Nuclear Medicine, Shanghai Cancer Center, Fudan University, Department of Oncology, Shanghai Medical College, Shanghai, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Min Zhou
1Nuclear Medicine, Shanghai Cancer Center, Fudan University, Department of Oncology, Shanghai Medical College, Shanghai, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
ZhiFeng Yao
1Nuclear Medicine, Shanghai Cancer Center, Fudan University, Department of Oncology, Shanghai Medical College, Shanghai, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Yingjian Zhang
1Nuclear Medicine, Shanghai Cancer Center, Fudan University, Department of Oncology, Shanghai Medical College, Shanghai, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
Loading

Article Information

vol. 53 no. supplement 1 67

Published By 
Society of Nuclear Medicine
Print ISSN 
0161-5505
Online ISSN 
2159-662X
History 
  • Published online November 4, 2014.

Copyright & Usage 
© 2012

Author Information

  1. LingLing Pan1,
  2. Jingyi Cheng1,
  3. Min Zhou1,
  4. ZhiFeng Yao1 and
  5. Yingjian Zhang1
  1. 1Nuclear Medicine, Shanghai Cancer Center, Fudan University, Department of Oncology, Shanghai Medical College, Shanghai, China

Statistics from Altmetric.com

Cited By...

  • Citations
  • Google Scholar

This article has not yet been cited by articles in journals that are participating in Crossref Cited-by Linking.

Article usage

Article usage: February 2015 to April 2025

AbstractFullPdf
Feb 2015100
Jun 2015700
Jul 2015200
Sep 2015700
Nov 2015300
Jan 2016200
Mar 2016300
Apr 2016100
Jun 2016200
Jul 2016100
Aug 2016200
Oct 2016100
Nov 2016200
Dec 2016200
Jan 2017300
Mar 2017400
May 2017200
Aug 2017400
Sep 2017200
Oct 2017100
Nov 2017100
Jul 2018100
Aug 2018100
Sep 2018300
Oct 2018100
Nov 2018300
Apr 2019100
May 2019100
Jul 2019300
Feb 2020400
Mar 20201300
Apr 2020800
Jul 2020200
Aug 20201200
Sep 20202500
Oct 20201400
Nov 20201500
Dec 20201000
Jan 2021300
Feb 2021400
Mar 2021500
Apr 2021500
May 2021500
Jun 2021100
Jul 20211200
Aug 20212900
Sep 20211100
Oct 20211000
Nov 20215900
Dec 20213400
Jan 20226300
Feb 20221800
Mar 20221200
Apr 20222600
May 20222600
Jun 2022100
Jul 2022200
Aug 2022200
Sep 2022100
Oct 2022200
Jan 2023100
Mar 2023200
Apr 2023200
May 2023200
Jun 2023300
Jul 2023200
Aug 2023100
Sep 2023200
Oct 2023200
Nov 2023100
Dec 2023200
Jan 2024500
Mar 2024200
Apr 2024200
May 2024700
Jun 2024200
Jul 2024200
Aug 20241100
Sep 2024900
Oct 2024200
Nov 2024300
Dec 2024500
Feb 2025200
Mar 2025300
Apr 2025400
Back to top

In this issue

Journal of Nuclear Medicine
Vol. 53, Issue supplement 1
May 2012
  • Table of Contents
  • Index by author
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
The SUVmax (maximum standardized uptake value for F-18 fluorodeoxyglucose) and serum squamous cell carcinoma antigen (SCC-ag) function as prognostic biomarkers in patients with primary cervical cancer
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
The SUVmax (maximum standardized uptake value for F-18 fluorodeoxyglucose) and serum squamous cell carcinoma antigen (SCC-ag) function as prognostic biomarkers in patients with primary cervical cancer
LingLing Pan, Jingyi Cheng, Min Zhou, ZhiFeng Yao, Yingjian Zhang
Journal of Nuclear Medicine May 2012, 53 (supplement 1) 67;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
The SUVmax (maximum standardized uptake value for F-18 fluorodeoxyglucose) and serum squamous cell carcinoma antigen (SCC-ag) function as prognostic biomarkers in patients with primary cervical cancer
LingLing Pan, Jingyi Cheng, Min Zhou, ZhiFeng Yao, Yingjian Zhang
Journal of Nuclear Medicine May 2012, 53 (supplement 1) 67;
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
  • Figures & Data
  • Info & Metrics

Related Articles

  • No related articles found.
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

Oncology: Clinical Diagnosis

  • High detection performance and accurate staging of adrenal glands using state-of-the-art PET/CT
  • A regression model to predict tumor cellularity in patients with prostate cancer and low FDG uptake
  • Prediction of Response to Neoadjuvant Chemotherapy in Osteosarcoma using Dual-phase 18F-FDG PET/CT
Show more Oncology: Clinical Diagnosis

Molecular Imaging in Gynecological Oncology

  • Role of FDG PET/CT in the preoperative staging of high-risk clinical early stage endometrial cancer
  • FDG PET early metabolic response to the PARP inhibitor olaparib (AZD2281) in BRCA-deficient or recurrent high-grade ovarian carcinoma and BRCA-deficient or triple-negative breast cancer
Show more Molecular Imaging in Gynecological Oncology

Similar Articles

SNMMI

© 2025 SNMMI

Powered by HighWire